Testing a new sputum test for lung cancer in high-risk adults
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This study tests a new, non-invasive sputum test (FlowPath Lung) to see if it can accurately detect lung cancer in people at high risk who have a lung nodule. If you are between 50 and 80, have a smoking history, and have a lung nodule, this test may help decide if further steps are needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 80 years old.
- You are a current or former smoker with at least a 20 pack-year smoking history (for example, 1 pack a day for 20 years).
- You have a lung nodule (spot) that is 6 to 30 mm wide (about the size of a pea to a grape) found on a CT scan.
- You can cough up a sputum (phlegm) sample.
- You have not had lung cancer in the last 5 years, or any other cancer (except skin cancer) in the last 2 years.
- You do not have a weakened immune system, such as from rheumatoid arthritis or immunosuppressant drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to see if a blood test can tell if a lung nodule is cancerous or not. It may help doctors avoid unnecessary procedures.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks for blood “biomarkers” (measurable signs in blood) that may help predict who is at higher or lower risk related to lung cancer. You would have blood samples taken and then be followed with visits for up to 3 years.
This study is collecting blood samples from people with lung nodules to help design a better test for lung cancer. It may help find cancer earlier without invasive procedures.
This study collects sputum (mucus from deep in the lungs) to help test or label lung cancer-related results. You may be placed in a healthy, high-risk, or cancer group depending on your smoking history and whether you already have a lung cancer diagnosis.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.